| Study |
Time |
Treat group |
Outcome |
No.improved |
No.of pts. |
Risk (% occurrence) |
Risk Difference |
NNT |
| Dickson 2001 |
5‐13 wk |
E: Hylan G‐F 20 |
Number of patients very good/good |
29 |
42 |
69 |
21 |
4.8 |
| |
|
C: Arthrocentesis |
|
23 |
48 |
48 |
|
|
| Dickson 2001 |
5‐13 wk |
E: Hylan G‐F 20 |
Number of patients very good/good |
29 |
42 |
69 |
14 |
7.1 |
| |
|
C:Diclofenac + arthrocentesis |
|
35 |
42 |
83 |
|
|
| Adams 1995 |
14‐26 wk |
E: Hylan G‐F 20 |
Number of patients rating treatment excellent, very good, good |
17 |
27 |
63 |
24 |
4.2 |
| |
|
C: NSAID + arthrocentesis |
|
12 |
31 |
39 |
|
|
| Adams 1995 |
14‐26 wk |
E: Hylan G‐F 20 + NSAID |
Number of patients rating treatment excellent, very good, good |
17 |
27 |
63 |
7 |
14.3 |
| |
|
C: NSAID + arthrocentesis |
|
18 |
32 |
56 |
|
|
| Raynauld 2002 |
45‐52 wk |
E: Hylan G‐F 20 + Appropriate Care |
Number of patients improved in study knee |
93 |
127 |
73 |
46 |
2.2 |
| |
|
C: Appropriate care |
|
35 |
128 |
27 |
|
|
